## MTD: Mettler-Toledo International Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 2.8% below STRENGTH zone (4.0-10.0%); PEG 5.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1389.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Mettler-Toledo International Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference**
- Source: Business Wire | 20260105T213208 | Neutral | Relevance: 100%
- Mettler-Toledo International Inc. announced it will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. Pacific Standard Time. A live webcast of the presentation will be available on the Companyâ€™s investor relations website. The company is a global supplier of precision instruments and services with strong market leadership.

**2. Harvey Investment Co. LLC Sells 3,611 Shares of Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20260105T132935 | Neutral | Relevance: 100%
- Harvey Investment Co. LLC reduced its stake in Mettler-Toledo International (NYSE: MTD) by 26.8%, selling 3,611 shares and now owning 9,878 shares valued at $12.126 million. The move comes as insider selling activities were noted, with CFO Shawn Vadala selling 1,895 shares and other insiders selling 19,565 shares over 90 days. Mettler-Toledo has a "Hold" rating from analysts with an average target price of $1,441.67, and recently beat quarterly earnings estimates.

**3. Asset Management One Co. Ltd. Grows Position in Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20260105T092934 | Neutral | Relevance: 100%
- Asset Management One Co. Ltd. increased its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 4.8% in the third quarter, bringing its total holdings to 21,386 shares valued at approximately $26.25 million. Institutional investors now own about 95.07% of the company's stock, while insiders have been net sellers, with CEO Patrick Kaltenbach and another insider selling shares totaling over $3.2 million. Analyst ratings for Mettler-Toledo are mixed, with a consensus "Hold" rating and an average price target of $1,441.67, though some firms have upgraded the stock to "Buy."

**4. Mettler-Toledo International (NYSE:MTD) Upgraded by Wall Street Zen to Buy Rating**
- Source: MarketBeat | 20260103T063755 | Somewhat-Bullish | Relevance: 100%
- Wall Street Zen upgraded Mettler-Toledo International (NYSE:MTD) from a "hold" to a "buy" rating, though the consensus among analysts remains a "Hold" with a target price of $1,441.67. The company surpassed its Q3 earnings estimates with EPS of $11.15 and revenue of $1.03 billion, and provided optimistic Q4 and FY2025 EPS guidance. Despite notable insider selling, institutional investors hold a significant majority of the stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Barclays | $1550 | $1600 | -3% |
| 2025-12-15 | Wells Fargo | $1450 | $1400 | +4% |
| 2025-12-09 | Goldman Sachs | $1475 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Barclays | main | Overweight |
| 2025-12-15 | Wells Fargo | main | Equal-Weight |
| 2025-12-09 | Goldman Sachs | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 18 ($1.28M) |
| Sells | 6 ($0.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+1.4%)
- Blackrock Inc.: 9.2% (-3.1%)
- State Street Corpora: 4.7% (-0.5%)
- Capital Internationa: 4.2% (+1.2%)
- Bank Of New York Mel: 4.0% (-9.0%)

### Key Risks

1. Valuation stretched: PEG 5.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +2.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 5.76 signals overvaluation risk, limited margin of safety. Forward P/E 31.6x stretched relative to 8% growth. Quality metrics strong (ROE 30%, ROA 20%, margin 21%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.8B |
| Beta | 1.42 |
| 52W Range | $946.69 - $1525.17 |
| Short Interest | 3.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.76 |
| Forward P/E | 31.6 |
| Current P/E | 34.3 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 0.2% to 2.8% (+2.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.2pp (needs >4.0% for momentum thesis). MRS_5 at 1.9% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.41), confirming momentum. RSI neutral at 59. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.76% (CS: 71) | Neutral |
| RSI_14 | 58.9 | Neutral |
| MACD Histogram | 2.41 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 1.151x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1446.59
- **Stop Loss:** $1389.47 (3.9% risk)
- **Target:** $1503.71 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 15
- **Position Value:** $21,698.85
- **Portfolio %:** 21.70%
- **Risk Dollars:** $862.50
- **Risk Per Trade:** 0.86%
- **Modifiers:** L1 115% | L2 75% | Combined 0.86x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-05 (Est: $12.80)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $10.66 | $11.15 | +4.6% |
| 2025Q2 | $9.60 | $10.09 | +5.1% |
| 2025Q1 | $7.88 | $8.19 | +3.9% |
| 2024Q4 | $11.72 | $12.41 | +5.8% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*